Home  >  News
Eppen_PCR_Ape25
you can get e-magazine links on WhatsApp. Click here
Health & Insurance + Font Resize -

C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain

Our Bureau, Bengaluru
Tuesday, October 15, 2024, 15:15 Hrs  [IST]

The International Centre for Antimicrobial Resistance Solutions (ICARS) has signed a partnership with the Centre for Cellular and Molecular Platforms (C-CAMP), under the aegis of the India AMR Innovation Hub (IAIH), to tackle the growing threat of antimicrobial resistance (AMR) across the One Health domain.

One Health is an approach that recognises that human health is closely connected to the health of animals and our shared environment.

As a part of this partnership under the aegis of the India AMR Innovation Hub (IAIH), ICARS will strive to provide funding support over the next five years, and technical expertise and network for implementation research jointly with C-CAMP, aligning with India’s National Action Plan on AMR (NAP 2.0). Additionally, ICARS and C-CAMP will work together to mobilise further funding to expand efforts and create a wider impact.

The partnership will focus on identifying, developing, and scaling innovative solutions to tackle AMR in India, with potential expansion to other low- and middle-income countries (LMICs). The partnership also aims to bring together a network of Indian stakeholders actively working on AMR-related challenges.

Dr Taslimarif Saiyed, director-CEO, C-CAMP said, “In India we are yet to recognise health, food and environment holistically as One Health and have a go-to pipeline of proven solutions whether that be technology, implementation or framework. With this partnership, under India AMR Innovation Hub (IAIH), we are committed to change this scenario.”

Prof Ajay Sood, principal scientific adviser to the Government of India said: “As India’s AMR NAP 2.0 comes up, such partnerships will provide crucial perspective, guidance and significant support in navigating the formidable multi-sectoral challenge of One Health.”

Ambassador at the Royal Danish Embassy in New Delhi, Freddy Svane, said: “Drug resistance is a growing threat to global health. ICARS holds the key for raising awareness and advocacy. With the MoU between ICARS and C-CAMP, a new step is taken in tackling AMR in India and beyond. A one health approach is crucial.”

Henrik Wegener, Board Chair, ICARS, said: “We look forward to working with C-CAMP and other stakeholders to identify, develop and test AMR solutions that will deliver meaningful impact and address One Health AMR challenges in India.”

Dr Sujith J. Chandy, executive director, ICARS said, “As India implements its National Action Plan 2.0, our partnership will help to support the development of sustainable and innovative One Health solutions that align with national plans and can be scaled up to respond to the ever-growing threat of AMR."

The objective of the partnership are to support identification and prioritisation of India specific One Health AMR challenges and strategies to tackle them. To foster innovative evidence-based solutions that address these AMR challenges by leveraging promising cutting-edge research, technology, and data-driven insights.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
Avians_2025
API_China_2025
chemexpoindia
ana-Lab-India_25
ProPak_Asia_2025
Oligonucleotides_Workshop25
CPHI_PMEC_China_2025
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram